Novel role of resveratrol: Suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury

Shock

Volumn 42, Issue 5, 2014, Pages 440-447

  Xu, Wei ^a   Lu, Yang ^a   Yao, Jihong ^a   Li, Zhenlu ^a   Chen, Zhao ^a   Wang, Guangzhi ^a   Jing, Huirong ^a   Zhang, Xinyuan ^a   Li, Mingzhu ^a   Peng, Jinyong ^a   Tian, Xiaofeng ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

deacetylation; HMGB1; liver injury; nucleocytoplasmic translocation; resveratrol; sepsis; SIRT1

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHEMOKINE; HIGH MOBILITY GROUP B1 PROTEIN; MALONALDEHYDE; NICOTINAMIDE; RESVERATROL; SIRTUIN 1; SMALL INTERFERING RNA; HBP1 PROTEIN, RAT; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CELL PROTECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; ENZYME ACTIVITY; FEEDING; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KUPFFER CELL; LIVER CELL; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; OXIDATIVE STRESS; PROTEIN ACETYLATION; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RNA INTERFERENCE; TREATMENT DURATION; UPREGULATION; ACETYLATION; ACUTE LUNG INJURY; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL NUCLEUS; COMPLICATION; DRUG EFFECTS; DRUG SCREENING; GENE SILENCING; GENE TRANSLOCATION; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SEPSIS; SPRAGUE DAWLEY RAT;

ACETYLATION; ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; DRUG EVALUATION, PRECLINICAL; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTES; HMGB1 PROTEIN; MALE; MOLECULAR TARGETED THERAPY; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; SEPSIS; SIRTUIN 1; STILBENES; TRANSLOCATION, GENETIC; UP-REGULATION;

EID: 84925776940     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000225     Document Type: Article

References (35)

1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 369(9): 840-851, 2013
2. BianchiME, Manfredi AA. Immunology. Dangers in and out. Science 323(5922): 1683-1684, 2009
3. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29: 139-162, 2011
4. Zhou RR, Zhao SS, Zou MX, Zhang P, Zhang BX, Dai XH, Li N, Liu HB, Wang H, Fan XG. HMGB1 cytoplasmic translocation in patients with acute liver failure. BMC Gastroenterol 11: 21, 2011
5. Wang H, Zhu S, Zhou R, Li W, Sama AE. Therapeutic potential of HMGB1-Targeting agents in sepsis. Expert Rev Mol Med 10: e32, 2008
6. Yang H, Wang H, Tracey KJ. HMG-1 rediscovered as a cytokine. Shock 15(4): 247-253, 2001
7. Mantell LL, Parrish WR, Ulloa L. HMGB-1 as a therapeutic target for infectious and inflammatory disorders. Shock 25(1): 4-11, 2006
8. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H. HMGB1 signals through Toll-like receptor (TLR) 4 and TLR2. Shock 26(2): 174-179, 2006
9. Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, Musco G, Sitia G, Yap GS, Wan Y, Biron CA, et al.: A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110(6): 1970-1981, 2007
10. Liu G, Wang J, Park YJ, Tsuruta Y, Lorne EF, Zhao X, Abraham E. High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J Immunol 181(6): 4240-4246, 2008
11. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22(20): 5551-5560, 2003
12. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a nonclassical, vesicle-mediated secretory pathway. EMBO Rep 3(10): 995-1001, 2002
13. Evankovich J, Cho SW, Zhang R, Cardinal J, Dhupar R, Zhang L, Klune JR, Zlotnicki J, Billiar T, Tsung A. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem 285(51): 39888-39897, 2010
14. He M, Zhang B, Wei X, Wang Z, Fan B, Du P, Zhang Y, Jian W, Chen L, Wang L, et al. HDAC4/5-HMGB1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury. J CellMolMed 17(4): 531-542, 2013
15. Lee OH, Kim J, Kim JM, Lee H, Kim EH, Bae SK, Choi Y, Nam HS, Heo JH. Decreased expression of sirtuin 6 is associated with release of high mobility group box-1 after cerebral ischemia. Biochem Biophys Res Commun 438(2): 388-394, 2013
16. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 404(1): 1-13, 2007
17. Zhou Y, Schmitz KM, Mayer C, Yuan X, Akhtar A, Grummt I. Reversible acetylation of the chromatin remodelling complex NoRC is required for noncoding RNA-dependent silencing. Nat Cell Biol 11(8): 1010-1016, 2009
18. Xu F, Burk D, Gao Z, Yin J, Zhang X, Weng J, Ye J. Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1j/j mice. Endocrinology 153(4): 1706-1716, 2012
19. Hao CM, Haase VH. Sirtuins and their relevance to the kidney. J Am Soc Nephrol 21(10): 1620-1627, 2010
20. Carneiro VC, de Moraes MR, de Abreu DSI, Da CR, Paiva CN, Bozza MT, Fantappie MR. The extracellular release of Schistosoma mansoni HMGB1 nuclear protein is mediated by acetylation. Biochem Biophys Res Commun 390(4): 1245-1249, 2009
21. Shankar S, Singh G, Srivastava RK. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 12: 4839-4854, 2007
22. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425(6954): 191-196, 2003
23. Smeding L, Leong-Poi H, Hu P, Shan Y, Haitsma JJ, Horvath E, Furmli S, Masoom H, Kuiper JW, Slutsky AS, et al. Salutary effect of resveratrol on sepsis-induced myocardial depression. Crit Care Med 40(6): 1896-1907, 2012
24. Xie J, Wan J, Jiang R, Lu H, Peng X, Zhang L. Upregulation of Sirt1 in carbontetrachlorideYinduced acute liver injury. Drug Chem Toxicol 36(3): 277-283, 2013
25. Muftuoglu MA, Aktekin A, Ozdemir NC, Saglam A. Liver injury in sepsis and abdominal compartment syndrome in rats. Surg Today 36(6): 519-524, 2006
26. Huang ZB, Dai XH, Xiao MF, Zhou RR, Zhao SS, Zhang BX, Yi PP, Chen RC, Li WT, Yaser AM, et al. HMGB1 release by human liver L02 and HepG2 cells induced by lipopolysaccharide. Mol Med Rep 8(1): 103-112, 2013
27. Zhai X, Lin M, Zhang F, Hu Y, Xu X, Li Y, Liu K, Ma X, Tian X, Yao J. Dietary flavonoid genistein induces Nrf2 and phase II detoxification gene expression via ERKs and PKC pathways and protects against oxidative stress in Caco-2 cells. Mol Nutr Food Res 57(2): 249-259, 2013
28. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50(1): 261-274, 2009
29. Ajmo JM, Liang X, Rogers CQ, Pennock B, You M. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 295(4): G833-G842, 2008
30. Kolgazi M, Sener G, Cetinel S, Gedik N, Alican I. Resveratrol reduces renal and lung injury caused by sepsis in rats. J Surg Res 134(2): 315-321, 2006
31. Sakaguchi M, Murata H, Yamamoto K, Ono T, Sakaguchi Y, Motoyama A, Hibino T, Kataoka K, Huh NH. TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS One 6(8): e23132, 2011
32. Luo Y, Chihara Y, Fujimoto K, Sasahira T, Kuwada M, Fujiwara R, Fujii K, Ohmori H, Kuniyasu H. High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy. Eur J Cancer 49(3): 741-751, 2013
33. Stein S, Matter CM. Protective roles of SIRT1 in atherosclerosis. Cell Cycle 10(4): 640-647, 2011
34. Holthoff JH, Wang Z, Seely KA, Gokden N, Mayeux PR. Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury. Kidney Int 81(4): 370-378, 2012
35. Chen G, Li J, Qiang X, Czura CJ, Ochani M, Ochani K, Ulloa L, Yang H, Tracey KJ, Wang P, et al. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine: an additional mechanism for its therapeutic effects in experimental sepsis. J Lipid Res 46(4): 623-627, 2005